Halo Collective (BST:A9KN) - Prezzo delle azioni, notizie e analisi

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

A9KN Panoramica delle azioni

Engages in the cultivation, manufacture, transportation, and distribution of cannabis and cannabis extracts in Canada and the United States.

Informazioni sull'azienda

A9KN analisi fondamentale
Punteggio fiocco di neve
Valutazione	2/6
Crescita futura	0/6
Prestazioni passate	0/6
Salute finanziaria	6/6
Dividendi	0/6

Premi

Analisi del rischio

Gli utili sono diminuiti del 48.7% all'anno negli ultimi 5 anni

Non ha una capitalizzazione di mercato significativa ( €1M )

Gli azionisti sono stati sostanzialmente diluiti nell'ultimo anno

Le azioni sono altamente illiquide

Halo Collective Inc. Concorrenti

Biofrontera

XTRA:B8FK

€14.3m

SynBiotic

DUSE:SBX

€30.3m

Redx Pharma

DB:0RX

€65.0m

Cantourage Group

XTRA:HIGH

€63.0m

Storia dei prezzi e prestazioni

Riepilogo dei massimi storici, delle variazioni e dei cali di prezzo di tutti i tempi per Halo Collective
Prezzi storici delle azioni
Prezzo attuale dell'azione	US$0.26
Massimo di 52 settimane	US$4.07
Minimo di 52 settimane	US$0.066
Beta	1.96
1Variazione di 1 mese	0%
Variazione a 3 mesi	229.30%
Variazione di 1 anno	-93.17%
3Variazione a 3 anni	-99.68%
Variazione a 5 anni	n/a
Variazione dall'IPO	-99.83%

Notizie e aggiornamenti recenti

Recent updates

Rendimenti per gli azionisti

	A9KN	DE Pharmaceuticals	DE Mercato
7D	0%	2.9%	3.1%
1Y	-93.2%	-11.5%	13.3%

Ritorno vs Industria: A9KN ha avuto una performance inferiore rispetto al German Pharmaceuticals che ha registrato un rendimento -13.5 % nell'ultimo anno.

Rendimento vs Mercato: A9KN ha avuto una performance inferiore al mercato German che ha registrato un rendimento 4.7 % nell'ultimo anno.

Volatilità dei prezzi

Is A9KN's price volatile compared to industry and market?
A9KN volatility
A9KN Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	5.4%
Market Average Movement	5.0%
10% most volatile stocks in DE Market	11.4%
10% least volatile stocks in DE Market	2.4%

Prezzo delle azioni stabile: Il prezzo delle azioni di A9KN è stato volatile negli ultimi 3 mesi.

Volatilità nel tempo: Dati insufficienti per determinare la variazione della volatilità di A9KN nell'ultimo anno.

Informazioni sull'azienda

Fondato	I dipendenti	AMMINISTRATORE DELEGATO	Sito web
2016	276	Katie Field	www.haloco.com

Halo Collective Inc. Riepilogo dei fondamenti

Come si confrontano gli utili e i ricavi di Halo Collective con la sua capitalizzazione di mercato?
A9KN statistiche fondamentali
Capitalizzazione di mercato	€1.10m
Guadagni(TTM)	-€87.07m
Ricavi(TTM)	€26.08m

0.0x

Rapporto P/S

0.0x

Rapporto P/E

A9KN è sopravvalutato?

Vedi Fair Value e analisi di valutazione

Guadagni e ricavi

Statistiche chiave sulla redditività dall'ultima relazione sugli utili (TTM)
A9KN Conto economico (TTM)
Ricavi	US$28.34m
Costo del fatturato	US$24.54m
Profitto lordo	US$3.80m
Altre spese	US$98.41m
Guadagni	-US$94.61m

Ultimi guadagni dichiarati

Sep 30, 2022

Prossima data di guadagno

n/a

Utile per azione (EPS)	-1.39
Margine lordo	13.40%
Margine di profitto netto	-333.86%
Rapporto debito/patrimonio netto	18.3%

Come si è comportato A9KN nel lungo periodo?

Vedi performance storica e confronto

A9KN Panoramica delle azioni

Premi

Analisi del rischio

Halo Collective Inc. Concorrenti

XTRA:B8FK

€14.3m

DUSE:SBX

€30.3m

DB:0RX

€65.0m

XTRA:HIGH

€63.0m

Storia dei prezzi e prestazioni

Notizie e aggiornamenti recenti

Halo Collective Inc. Announces Change to Board of Directors

Halo Collective Inc. Announces Expansion of Cannabis Genetics and Strain Portfolio, Specifically Within Its Oregon Operations

Halo Collective Inc., Annual General Meeting, Mar 24, 2023

Halo Collective Inc. announced that it has received $6.99999 million in funding from Agilent Technologies, Inc., Research Corporation Technologies, BroadOak Capital Partners LLC, Investment Arm, BioAdvance, and other investors

Halo Collective Inc. Announces Launch of New Premium Cannabis Strains

Second quarter 2022 earnings released: US$1.61 loss per share (vs US$11.41 loss in 2Q 2021)

Recent updates

Halo Collective Inc. Announces Change to Board of Directors

Halo Collective Inc. Announces Expansion of Cannabis Genetics and Strain Portfolio, Specifically Within Its Oregon Operations

Halo Collective Inc., Annual General Meeting, Mar 24, 2023

Halo Collective Inc. announced that it has received $6.99999 million in funding from Agilent Technologies, Inc., Research Corporation Technologies, BroadOak Capital Partners LLC, Investment Arm, BioAdvance, and other investors

Halo Collective Inc. Announces Launch of New Premium Cannabis Strains

Second quarter 2022 earnings released: US$1.61 loss per share (vs US$11.41 loss in 2Q 2021)

Halo Collective Inc. Appoints Katie Field as Chairman of the Board

Halo Collective Receives All Regulatory Approvals for Its Third Budega Dispensary in Hollywood, Halo's First Superstore

Halo Collective Inc. announced that it has received $6 million in funding from Agilent Technologies, Inc., Research Corporation Technologies, BroadOak Capital Partners LLC, Investment Arm, BioAdvance and other investors

Halo Collective Inc. announced that it has received $5.999994 million in funding

Halo Collective Inc. Announces Management Changes

First quarter 2022 earnings released: US$0.28 loss per share (vs US$0.56 loss in 1Q 2021)

Halo Collective Inc. Announces Resignation of Philip Van Den Berg as Chief Financial Officer

Halo Collective Inc. Receives Final Approvals from the Los Angeles Department of Cannabis Regulation & California Department of Cannabis Control and the State Department of Cannabis Control

High number of new directors

Full year 2021 earnings released: US$4.12 loss per share (vs US$7.27 loss in FY 2020)

Less than half of directors are independent

Halo Collective Announces Changes to Board of Directors

Halo Collective Inc. Receives All Approvals for Budega™ Dispensary in North Hollywood, California

Halo Collective Inc. Receives All Approvals for Budega™ Dispensary in North Hollywood, California

Halo Collective Inc. (OTCPK:HCAN.F) completed the acquisition of 1285826 B.C. Ltd. from 1337617 B.C. Ltd., 1253540 B.C. Ltd. and NKG Investments Ltd.

Halo Collective Inc. announced that it expects to receive CAD 14 million in funding from Alpha Blue Ocean Investment Group

Halo Collective Receives Local Approvals for Budega™ Dispensary in Los Angeles's Noho Arts District

Halo Collective Inc. (OTCPK:HCAN.F) entered into an agreement to acquire 1285826 B.C. Ltd. for $7 million.

Third quarter 2021 earnings released: US$0.40 loss per share (vs US$0.42 loss in 3Q 2020)

High number of new directors

High number of new directors

Halo Collective Inc. Announces the Official Launch of Ztrawberriez and 4 Prophets Premium Cannabis Flower

Halo Collective Inc. Announces FlowerShop, a Sensory-Care™ Brand Launches New Product Line, BUDVASE

Halo Collective Announces Reorganization of International Assets to Create Akanda

Halo Collective Inc. Provides Earnings Guidance for the Year 2021

Halo Collective Inc. Provides Sales Guidance for the Month Ended April 2021

Halo Collective Inc. announced that it expects to receive CAD 1 million in funding

Halo Collective Inc. has completed a Composite Units Offering in the amount of CAD 10.000025 million.

PeakBirch Logic Inc. Announces Partnership with Halo Collective Inc. to Develop Functional Mushroom Line

Halo Collective Inc. Enters into Partnership with Nightingale Remedies (Nightingale) and PeakBirch Logic Inc

Halo Collective Inc. has completed a Composite Units Offering in the amount of CAD 8.00154 million.

Halo Labs Inc. (OTCPK:AGEE.F) completed the acquisition of 1275111 B.C. Ltd.

Halo Labs Inc. announced that it expects to receive CAD 2.25 million in funding

Chief Financial Officer recently sold €95k worth of stock

Red Light Holland and Halo Labs Announce Intention to Enter Oregon Medicinal Psilocybin Market

Third quarter 2020 earnings released: US$0.006 loss per share

Halo Labs Inc. Appoints Annmol Sidhu to the Board of Directors

Halo Labs Inc. (OTCPK:AGEE.F) completed the acquisition of CanMart Ltd from David Keith Dean and Darran William Quinn.

Fred Leigh Resigns to Halo Labs Inc.'s Board of Directors

Halo Labs Inc. (OTCPK:AGEE.F) entered into a binding Letter of Intent to acquire CanMart Ltd for CAD 4.6 million.

Halo Labs Inc. (OTCPK:AGEE.F) entered into an amended asset purchase agreement to acquire three operating KushBar retail cannabis stores from KushBar Inc. for CAD 3.4 million.

Halo Labs Inc. (OTCPK:AGEE.F) completed the acquisition of 1265292 B.C. Ltd.

Halo Labs Inc. (OTCPK:AGEE.F) completed the acquisition of the remaining 85.28% stake in Ukiah Ventures Inc. from Odyssey Trust Company and others.

Earnings released

Halo Labs Inc. (OTCPK:AGEE.F) entered into a share exchange agreement to acquire the remaining 85.28% stake in Ukiah Ventures Inc. for $6.5 million.

Halo Labs Inc. (OTCPK:AGEE.F) completed the acquisition of 66.7% stake in LKJ11 LLC.

Halo Labs Inc. (OTCPK:AGEE.F) entered into a binding agreement to acquire a dispensary in Los Angeles.

Rendimenti per gli azionisti

Volatilità dei prezzi

Informazioni sull'azienda

Halo Collective Inc. Riepilogo dei fondamenti

0.0x

0.0x